Ameritas Investment Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,881
| Closed | -$737K | – | 3092 |
|
|
2022
Q3 | $737K | Buy |
4,881
+209
| +4% | +$31.6K | 0.03% | 634 |
|
|
2022
Q2 | $680K | Buy |
4,672
+321
| +7% | +$46.7K | 0.03% | 672 |
|
|
2022
Q1 | $516K | Hold |
4,351
| – | – | 0.02% | 795 |
|
|
2021
Q4 | $600K | Hold |
4,351
| – | – | 0.02% | 767 |
|
|
2021
Q3 | $604K | Buy |
4,351
+115
| +3% | +$16K | 0.02% | 746 |
|
|
2021
Q2 | $411K | Buy |
4,236
+206
| +5% | +$20K | 0.01% | 847 |
|
|
2021
Q1 | $275K | Hold |
4,030
| – | – | 0.01% | 1007 |
|
|
2020
Q4 | $345K | Sell |
4,030
-138
| -3% | -$11.8K | 0.02% | 871 |
|
|
2020
Q3 | $271K | Hold |
4,168
| – | – | 0.01% | 899 |
|
|
2020
Q2 | $305K | Buy |
4,168
+708
| +20% | +$51.8K | 0.01% | 852 |
|
|
2020
Q1 | $118K | Hold |
3,460
| – | – | 0.01% | 1179 |
|
|
2019
Q4 | $188K | Buy |
3,460
+208
| +6% | +$11.3K | 0.01% | 1132 |
|
|
2019
Q3 | $136K | Buy |
3,252
+418
| +15% | +$17.5K | 0.01% | 1285 |
|
|
2019
Q2 | $124K | Buy |
2,834
+258
| +10% | +$11.3K | 0.01% | 1362 |
|
|
2019
Q1 | $133K | Buy |
2,576
+247
| +11% | +$12.8K | 0.01% | 1290 |
|
|
2018
Q4 | $86K | Hold |
2,329
| – | – | ﹤0.01% | 1492 |
|
|
2018
Q3 | $87K | Hold |
2,329
| – | – | ﹤0.01% | 1665 |
|
|
2018
Q2 | $92K | Sell |
2,329
-353
| -13% | -$13.9K | ﹤0.01% | 1605 |
|
|
2018
Q1 | $69K | Buy |
2,682
+1,804
| +205% | +$46.4K | ﹤0.01% | 1732 |
|
|
2017
Q4 | $24K | Hold |
878
| – | – | ﹤0.01% | 2364 |
|
|
2017
Q3 | $31K | Hold |
878
| – | – | ﹤0.01% | 2181 |
|
|
2017
Q2 | $22K | Buy |
+878
| New | +$22K | ﹤0.01% | 2410 |
|